1. Home
  2. GOVX vs NCRA Comparison

GOVX vs NCRA Comparison

Compare GOVX & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$0.80

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo Nocera Inc.

NCRA

Nocera Inc.

HOLD

Current Price

$2.10

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOVX
NCRA
Founded
2001
2002
Country
United States
Taiwan
Employees
19
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
GOVX
NCRA
Price
$0.80
$2.10
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
201.0K
4.0M
Earning Date
04-15-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,627,944.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.06
52 Week High
$4.40
$3.98

Technical Indicators

Market Signals
Indicator
GOVX
NCRA
Relative Strength Index (RSI) 40.83 59.36
Support Level $0.64 $0.93
Resistance Level $2.00 $2.54
Average True Range (ATR) 0.09 0.35
MACD 0.02 -0.03
Stochastic Oscillator 42.26 27.38

Price Performance

Historical Comparison
GOVX
NCRA

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: